Investors Sell Shares of UnitedHealth Group (UNH) on Strength (UNH)

Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading on Wednesday. $109.41 million flowed into the stock on the tick-up and $189.45 million flowed out of the stock on the tick-down, for a money net flow of $80.04 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $1.86 for the day and closed at $224.35

A number of analysts have issued reports on the company. Wells Fargo & Co reissued an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. BMO Capital Markets began coverage on UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 price objective on the stock. Citigroup upped their price objective on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research report on Wednesday, October 18th. Finally, Jefferies Group reaffirmed a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $224.98.

The company has a market cap of $215,879.17, a price-to-earnings ratio of 24.44, a P/E/G ratio of 1.65 and a beta of 0.66. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.17 earnings per share. sell-side analysts forecast that UnitedHealth Group Inc will post 9.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.

In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders sold 34,630 shares of company stock worth $7,669,416 in the last three months. 0.89% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Atlantic Trust Group LLC boosted its stake in UnitedHealth Group by 1.1% in the third quarter. Atlantic Trust Group LLC now owns 1,002,906 shares of the healthcare conglomerate’s stock valued at $196,418,000 after acquiring an additional 10,836 shares in the last quarter. AustralianSuper Pty Ltd acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $79,633,000. Parametric Portfolio Associates LLC boosted its stake in shares of UnitedHealth Group by 4.2% during the third quarter. Parametric Portfolio Associates LLC now owns 3,655,449 shares of the healthcare conglomerate’s stock worth $715,920,000 after buying an additional 146,133 shares during the period. Institutional & Family Asset Management LLC boosted its stake in shares of UnitedHealth Group by 4.6% during the third quarter. Institutional & Family Asset Management LLC now owns 19,346 shares of the healthcare conglomerate’s stock worth $3,789,000 after buying an additional 857 shares during the period. Finally, Steward Partners Investment Advisory LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $7,787,000. Institutional investors own 86.01% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.com-unik.info/2017/12/13/investors-sell-shares-of-unitedhealth-group-unh-on-strength-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

What are top analysts saying about UnitedHealth Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit